Sex hormones in the cardiovascular system.
Gender-associated differences in the development of cardiovascular diseases have been described in humans and animals. These differences could explain the low incidence of cardiovascular disease in women in the reproductive period, such as stroke, hypertension, and atherosclerosis. The cardiovascular protection observed in females has been attributed to the beneficial effects of estrogen on endothelial function. Besides estrogen, sex hormones are able to modulate blood pressure by acting on important systems as cardiovascular, renal, and neural. They can have complementary or antagonistic actions. For example, testosterone can raise blood pressure by stimulating the renin-angiotensin-aldosterone system, whereas estrogen alone or combined with progesterone has been associated with decreased blood pressure. The effects of testosterone in the development of cardiovascular disease are contradictory. Although some researchers suggest a positive effect, others indicate negative actions of testosterone. Estrogens physiologically stimulate the release of endothelium-derived vasodilator factors and inhibit the renin-angiotensin system. Although the cardioprotective effects of estrogen are widely appreciated, little is known about the effects of progesterone, which is commonly used in hormone replacement therapy. Progesterone has both vasodilatory and vasoconstrictive effects in the vasculature, depending on the location of the vessel and the level of exposure. Nevertheless, the mechanisms through which sex hormones modulate blood pressure have not been fully elucidated. Therefore, the characterization of those could lead to a better understanding of hypertension in women and men and perhaps to improved forms of therapy.
Roger Lyrio
RL
dos Santos
Fabrício Bragança
FB
da Silva
Rogério Faustino
RF
Ribeiro
Ivanita
I
Stefanon
D000818:Animals; D001794:Blood Pressure; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D002319:Cardiovascular System / Q000378:metabolism*; D004967:Estrogens / Q000378:metabolism / Q000627:therapeutic use; D012739:Gonadal Steroid Hormones / Q000378:metabolism* / Q000627:therapeutic use; D020249:Hormone Replacement Therapy; D006801:Humans; D011374:Progesterone / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D012737:Sex Factors
D004967:Estrogens; D012739:Gonadal Steroid Hormones; D020845:Selective Estrogen Receptor Modulators; D011374:Progesterone